Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease.
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Febuxostat (Primary)
- Indications Diabetic nephropathies
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 22 Jan 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
- 13 May 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.